|
2025
|
Invention
|
Combinations of plasminogen activator mutants and lysine analogs for inhibiting coagulation and a... |
|
|
Invention
|
Fc-cxcl14 fusion proteins. The present invention relates to a fusion protein comprising a CXCL14 ... |
|
|
Invention
|
Compounds and uses thereof as modulators of serotonin receptors. The present disclosure relates t... |
|
|
Invention
|
Tricer - a tri-specific cell engager and retainer. The present invention relates to a tri-specifi... |
|
|
Invention
|
Treatment of bacterial vaginosis.
A method of treating bacterial vaginosis in a subject is discl... |
|
|
Invention
|
Machine learning generation of corneal refractive power map. A method comprising receiving ocular... |
|
|
Invention
|
Thiazepine derivatives, pharmaceutical compositions, and uses in managing retinoic acid receptor-... |
|
2024
|
Invention
|
Diagnostic agents and uses thereof. The present disclosure relates to 2-deoxy-D-glucose (2DG) com... |
|
|
Invention
|
Preparation of retinal pigment epithelium cells.
A method of generating retinal pigment epitheli... |
|
|
Invention
|
Systems for applying functional near infra-red spectroscopy (fnirs) to a head of a subject. A sys... |
|
|
Invention
|
Conjugates and uses thereof. The present disclosure provides conjugates comprising at least one p... |
|
|
Invention
|
Heparanase-neutralizing a54 monoclonal antibody.
The present invention relates to an heparanase-... |
|
|
Invention
|
Immunomodulating peptides and uses thereof. The present invention relates to novel peptides havin... |
|
|
Invention
|
Peptide modulators of neuroligin 4-neurexin 1-beta axis for treatment of conditions that involve ... |
|
|
Invention
|
Inhibitors and combinations for treating diseases. The present disclosure relates to inhibitors, ... |
|
|
Invention
|
Peptide modulators of neuroligin 4-neurexin 1-beta axis for treatment of liver disorders.
Provid... |
|
|
Invention
|
Adaptable thin lens for correction of visual aberrations. The present invention provides an adapt... |
|
|
Invention
|
Graph convolution networks to identify and quantify gene and cancer specific transcriptome signat... |
|
|
Invention
|
Compounds for the treatment of glycogen storage disorders.
Compounds represented by general Form... |
|
|
Invention
|
Genetically engineered mucosal-associated invariant t (mait) cells for adoptive transfer cellther... |
|
|
Invention
|
Non-invasive central venous pressure monitoring device. This invention relates to a method and sy... |
|
|
Invention
|
Handheld apparatus for measuring intraocular pressure. An apparatus (100) for measuring an intrao... |
|
|
Invention
|
Personalized support device for mechanically affecting a pulsating organ's dynamic behavior. A su... |
|
|
Invention
|
Targeted reduction of cd59 for use in treating disease. The present disclosure provides methods o... |
|
|
Invention
|
Nucleic acid agents modulating fas isoforms. The present disclosure relates to manipulation of sp... |
|
|
Invention
|
Rapidly dissolving microneedle arrays comprising nanoparticles. Provided herein are rapidly disso... |
|
2023
|
Invention
|
Spinal treatment apparatus and method. Apparatus is provided including an intradural catheter (22... |
|
|
Invention
|
Variant-specific exogenous dna template-free correction of pathogenic variants.
Provided herein ... |
|
|
Invention
|
Devices, kits and methods for reducing and/or preventing intra-abdominal adhesions. Disclosed her... |
|
|
Invention
|
Methods of graft versus host disease diagnosis.
Methods of diagnosing graft versus host disease ... |
|
|
Invention
|
Modulators and uses thereof. The present disclosure relates to small molecule compound (SMC) modu... |
|
|
Invention
|
Machine learning identification of mutational signatures. A computer-implemented method comprisin... |
|
|
Invention
|
Combinations comprising psychedelics for the treatment of schizophrenia and other neuropsychiatri... |
|
|
Invention
|
Engineered t cell receptor constructs for cancer therapy. The invention relates to engineered T c... |
|
|
Invention
|
A combination for treating a retinal disease.
The present disclosure relates to combination the ... |
|
|
Invention
|
A combination for treating a retinal disease. The present disclosure relates to combination the c... |
|
|
Invention
|
Gene therapy for fam161a-associated retinopathies and other ciliopathies. The present invention i... |
|
|
Invention
|
Assessment of relative quantitative effect of somatic point mutations at the individual tumor lev... |
|
|
Invention
|
Combination of endocannabinoid and mtor inhibitors in the treatment of neuroendocrine neoplasms. ... |
|
|
Invention
|
Systems and methods for identifying position of electrodes in an eeg electrode array on a head of... |
|
|
Invention
|
Methods and compositions for treating vision loss.
Described herein are methods for differentiat... |
|
|
Invention
|
Compositions for removing microbial biofilm or inhibiting formation thereof.
Compositions contai... |
|
|
Invention
|
Anti-bcma car to target immune-related disorders, compositions and method thereof.
The present d... |
|
|
Invention
|
Antibody sequences of three antibody candidates targeting human lymphocyte antigen 6 family membe... |
|
2022
|
Invention
|
Compounds for neutrophil ros inhibition.
Methods of inhibiting reactive oxygen species productio... |
|
|
Invention
|
Lysosome-associated membrane protein targeting compounds and uses thereof.
Disclosed herein is a... |
|
|
Invention
|
Improved adoptive cell transfer therapy for cancer.
The present invention is directed to the fie... |
|
2021
|
Invention
|
Bioadhesive film and methods of use thereof.
A film and a method for use thereof such as for the... |
